基本信息
浏览量:160
职业迁徙
个人简介
Professor Toth is a chemical engineer with a research focus on medicinal chemistry. He was awarded his PhD in 1972 and has since worked in Hungary, Canada and the United Kingdom before relocating to Australia in 1998. His major research interests are drug delivery, immunoadjuvants, synthetic vaccines and gene delivery. His research has attracted over $60 million in competitive grants, research contracts and investment funds in the past 10 years. He has over 300 peer-reviewed publications, 43 patents, and an excellent track record in research commercialization as a key founder of Alchemia (ASX listed), Implicit Bioscience Pty Ltd, Neurotide Pty Ltd and TetraQ (the commercial arm of Centre of Integrated Preclinical Drug Development).
研究兴趣
论文共 987 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Lantian Lu, Wei Yang Kong,Jiahui Zhang, Farrhana Firdaus,James W Wells,Rachel J Stephenson,Istvan Toth,Mariusz Skwarczynski,Jazmina L Gonzalez Cruz
Frontiers in immunology (2024): 1298721-1298721
Vaccinesno. 3 (2024): 272
Vaccinesno. 2 (2024): 198
Journal of colloid and interface science (2024): 43-52
Comprehensive Analytical Chemistrypp.59-103, (2023)
引用0浏览0引用
0
0
ADVANCED FUNCTIONAL MATERIALSno. 12 (2023): 2209304-2209304
Tuberculosis (2023): 102307-102307
引用0浏览0WOS引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn